For the quarter ending 2026-03-31, OPRX has $167,264K in assets. $37,653K in debts. $20,169K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 20,169 | 23,365 | 19,519 | 16,585 |
| Accounts receivable, net of allowance for credit losses of 260 at march31, 2026 and december31, 2025 | 31,989 | 37,752 | 32,227 | 33,512 |
| Taxes receivable | 871 | 752 | 1,747 | 646 |
| Prepaid expenses and other | 3,136 | 2,846 | 2,827 | 3,337 |
| Total current assets | 56,165 | 64,715 | 56,320 | 54,080 |
| Property and equipment | - | 457 | - | - |
| Less accumulated depreciation | - | 351 | - | - |
| Property and equipment, net | 107 | 106 | 119 | 134 |
| Goodwill | 70,869 | 70,869 | 70,869 | 70,869 |
| Patent rights, net | - | - | 5,013 | 5,181 |
| Tradename and customer relationships, net | - | 29,340 | 30,042 | 30,634 |
| Patent rights, net | 4,426 | 4,586 | - | - |
| Technology assets, net | 6,576 | 6,870 | 7,382 | 7,677 |
| Customer relationships, net | 28,751 | - | - | - |
| Operating lease right-of-use assets | 352 | 404 | 481 | 528 |
| Security deposits and other assets | 18 | 28 | 95 | 162 |
| Total other assets | 110,992 | 112,097 | 113,882 | 115,051 |
| Total assets | 167,264 | 176,918 | 170,321 | 169,265 |
| Current portion of long-term debt | 2,000 | 4,255 | 3,300 | 3,300 |
| Accounts payable | 3,066 | 1,636 | 2,037 | 1,982 |
| Accrued expenses | 3,592 | 11,591 | 10,198 | 12,491 |
| Revenue share payable | 955 | 3,086 | 2,329 | 2,591 |
| Taxes payable | - | 0 | 0 | 0 |
| Current portion of lease liabilities | 177 | 193 | 207 | 209 |
| Deferred revenue | 669 | 503 | 395 | 484 |
| Total current liabilities | 10,459 | 21,264 | 18,466 | 21,057 |
| Long-term debt, net | 21,343 | 21,421 | 24,801 | 25,127 |
| Lease liabilities, net of current portion | 196 | 234 | 300 | 339 |
| Deferred tax liabilities, net | 5,655 | 5,705 | 4,491 | 3,458 |
| Total liabilities | 37,653 | 48,624 | 48,058 | 49,981 |
| Common stock, 0.001 par value, 166,666,667 shares authorized, 20,506,472 and 20,500,986 shares issued at march31, 2026 and december31, 2025, respectively | 21 | 20 | 20 | 20 |
| Treasury stock, 0.001 par value,1,741,397 shares purchased at december31, 2025 and 2024 | - | 2 | - | - |
| Treasury stock, 0.001 par value, 1,741,397 shares held at march31, 2026 and december31, 2025 | 2 | - | 2 | 2 |
| Additional paid-in-capital | 209,323 | 207,512 | 206,501 | 204,301 |
| Accumulated deficit | -79,731 | -79,236 | -84,256 | -85,035 |
| Total stockholders equity | 129,611 | 128,294 | 122,263 | 119,284 |
| Total liabilities and stockholders equity | 167,264 | 176,918 | 170,321 | 169,265 |
OptimizeRx Corp (OPRX)
OptimizeRx Corp (OPRX)